Pfizer Director Mortimer J. Buckley Receives Phantom Share Award

What Happened

• Mortimer J. Buckley, listed as a Director, was granted 1,307.987 derivative units (phantom shares) on 2026-09-25 at an imputed price of $28.67 per unit, with a stated total value of $37,500. The filing reports this as an acquisition/award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-09-25; 1,307.987 units at $28.67 per unit; total $37,500.
• Type: Derivative award (phantom share units), transaction code A.
• Shares owned after transaction: Not disclosed in this filing.
• Footnotes: F1 — each unit represents one phantom share of common stock. F2 — units are deferred director compensation (including dividend equivalents) and will be settled in cash or common stock at the director’s election following retirement from the Board.
• Filing timeliness: Reported on 2026-09-29; filed within the Form 4 two-business-day window for a 2026-09-25 transaction (timely).

Context

• These units are a form of deferred compensation for board service, not an open-market buy or sell; they do not directly signal a purchase-based bullish vote by the insider. Settlement may be in cash or shares upon the director’s retirement, per the footnote. Retail investors should view this as routine director compensation unless additional, non-routine transactions are reported.